IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines
Public ClinicalTrials.gov record NCT00770211. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Investigate the Efficacy and Safety of IncobotulinumtoxinA (Xeomin), Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines.
Study identification
- NCT ID
- NCT00770211
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Merz Pharmaceuticals GmbH
- Industry
- Enrollment
- 271 participants
Conditions and interventions
Conditions
Interventions
- IncobotulinumtoxinA (Xeomin) (20 Units) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2008
- Primary completion
- Feb 28, 2009
- Completion
- May 31, 2009
- Last update posted
- Oct 6, 2011
2008 – 2009
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| About Skin Dermatoloy | Englewood | Colorado | 80113 | — |
| Center for Cosmetic Enhancement | Aventura | Florida | 33180 | — |
| Frederic Brandt | Coral Gables | Florida | 33146 | — |
| Advanced Dermatology Research Institute | Lincolnshire | Illinois | 60069 | — |
| Laser & Skin Surgery Center of Indiana | Carmel | Indiana | 46032 | — |
| Joel Schlessinger | Omaha | Nebraska | 68144 | — |
| Image Dermatology P.C. | Montclair | New Jersey | 07042 | — |
| Rhoda Narins | White Plains | New York | 10604-2926 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00770211, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2011 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00770211 live on ClinicalTrials.gov.